Contrasting Cotiviti (COTV) & Its Rivals

Cotiviti (NYSE: COTV) is one of 20 public companies in the “Medical Software & Technology Services” industry, but how does it contrast to its rivals? We will compare Cotiviti to related businesses based on the strength of its valuation, dividends, risk, analyst recommendations, institutional ownership, earnings and profitability.

Analyst Recommendations

This is a summary of recent ratings and target prices for Cotiviti and its rivals, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cotiviti 0 3 6 0 2.67
Cotiviti Competitors 86 434 829 13 2.56

Cotiviti currently has a consensus price target of $41.29, suggesting a potential upside of 28.78%. As a group, “Medical Software & Technology Services” companies have a potential upside of 20.31%. Given Cotiviti’s stronger consensus rating and higher possible upside, analysts plainly believe Cotiviti is more favorable than its rivals.

Valuation and Earnings

This table compares Cotiviti and its rivals revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Cotiviti $625.16 million $48.85 million 33.05
Cotiviti Competitors $413.57 million -$24.55 million 399.35

Cotiviti has higher revenue and earnings than its rivals. Cotiviti is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Institutional & Insider Ownership

86.2% of Cotiviti shares are owned by institutional investors. Comparatively, 62.9% of shares of all “Medical Software & Technology Services” companies are owned by institutional investors. 15.8% of Cotiviti shares are owned by insiders. Comparatively, 26.5% of shares of all “Medical Software & Technology Services” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Profitability

This table compares Cotiviti and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Cotiviti 13.86% 13.61% 6.62%
Cotiviti Competitors -14.47% -7.21% 0.27%

Volatility & Risk

Cotiviti has a beta of 0.39, indicating that its share price is 61% less volatile than the S&P 500. Comparatively, Cotiviti’s rivals have a beta of 1.15, indicating that their average share price is 15% more volatile than the S&P 500.

Summary

Cotiviti beats its rivals on 9 of the 13 factors compared.

About Cotiviti

Cotiviti Holdings, Inc. is a provider of analytics-driven payment accuracy solutions. The Company focuses primarily on the healthcare sector. The Company operates through two segments: Healthcare, and Global Retail and Other. Through its Healthcare segment, the Company offers prospective and retrospective claims accuracy solutions to healthcare payers in the United States. The Company also provides analytics-based solutions unrelated to its healthcare payment accuracy solutions in the United States. Through its Global Retail and Other segment, the Company provides retrospective claims accuracy solutions to retailers primarily in the United States, Canada and the United Kingdom, as well as solutions that manage payment networks for a range of clients. The Company leverages its technology platform, configurable analytics, information assets and expertise in healthcare reimbursement to help its clients develop their claims payment accuracy.

Receive News & Ratings for Cotiviti Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cotiviti Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply